Sign In
Buy OGN
$13.56
+0 (+0%)
At Close: Aug 04, 2026
Organon: Valuation Discount Offset By Structural Headwinds
02:22pm, Tuesday, 12'th Aug 2025
Organon shares are very cheap, but weak growth, high debt, and a lack of clear catalysts make them a value trap rather than a bargain. Revenue is stagnating as new products only offset legacy declines
Investors Heavily Search Organon & Co. (OGN): Here is What You Need to Know
10:01am, Tuesday, 12'th Aug 2025
Zacks.com users have recently been watching Organon (OGN) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
OGN vs. HQY: Which Stock Is the Better Value Option?
12:41pm, Friday, 08'th Aug 2025
Investors interested in Medical Services stocks are likely familiar with Organon (OGN) and HealthEquity (HQY). But which of these two stocks is more attractive to value investors?
Organon Q2 Earnings: It May Be Time To Desert This Sinking Ship (Downgrade)
11:59am, Wednesday, 06'th Aug 2025
Organon & Co.'s shrinking revenues, heavy debt, and slashed dividend make it an unattractive investment despite its low valuation metrics. The Established Brands division is in decline, and new produc
Organon (OGN) Fiscal Q2 Revenue Beats 1%
02:47am, Wednesday, 06'th Aug 2025
Organon (OGN) Fiscal Q2 Revenue Beats 1%
Organon & Co. (OGN) Q2 2025 Earnings Call Transcript
01:10pm, Tuesday, 05'th Aug 2025
Organon & Co. (NYSE:OGN ) Q2 2025 Earnings Conference Call August 5, 2025 8:30 AM ET Company Participants Jennifer Halchak - Corporate Participant Juan Camilo Arjona Ferreira - Executive VP, Head of R
Organon (OGN) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates
12:01pm, Tuesday, 05'th Aug 2025
The headline numbers for Organon (OGN) give insight into how the company performed in the quarter ended June 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates
Organon (OGN) Beats Q2 Earnings and Revenue Estimates
09:46am, Tuesday, 05'th Aug 2025
Organon (OGN) came out with quarterly earnings of $1 per share, beating the Zacks Consensus Estimate of $0.94 per share. This compares to earnings of $1.12 per share a year ago.
Organon Reports Results for the Second Quarter Ended June 30, 2025
07:30am, Tuesday, 05'th Aug 2025
JERSEY CITY, N.J.--(BUSINESS WIRE)--Organon shares results for second quarter ended June 30, 2025.
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
09:51am, Monday, 04'th Aug 2025
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
Insights Into Organon (OGN) Q2: Wall Street Projections for Key Metrics
10:16am, Friday, 01'st Aug 2025
Get a deeper insight into the potential performance of Organon (OGN) for the quarter ended June 2025 by going beyond Wall Street's top-and-bottom-line estimates and examining the estimates for some of
Organon (OGN) Sees a More Significant Dip Than Broader Market: Some Facts to Know
06:50pm, Thursday, 31'st Jul 2025
In the most recent trading session, Organon (OGN) closed at $9.7, indicating a -3.39% shift from the previous trading day.
Organon (OGN) Expected to Beat Earnings Estimates: Should You Buy?
11:06am, Tuesday, 29'th Jul 2025
Organon (OGN) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Organon (OGN) Outperforms Broader Market: What You Need to Know
06:51pm, Friday, 25'th Jul 2025
In the latest trading session, Organon (OGN) closed at $10.21, marking a +1.39% move from the previous day.
Here is What to Know Beyond Why Organon & Co. (OGN) is a Trending Stock
10:01am, Wednesday, 23'rd Jul 2025
Organon (OGN) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
